表紙
市場調查報告書
商品編碼
1002592

PCR技術的全球市場 (∼2025年):技術 (傳統、qPCR、dPCR)、產品 (設備、試劑、軟體)、用途 (基因型鑑定、序列測定、基因表現、診斷)、終端用戶 (學術機構、醫藥品&生物科技企業、應用產業)、各地區

PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), Enduser (Academia, pharma-biotech, applied)-Global Forecast to 2025

出版日期: | 出版商: MarketsandMarkets | 英文 194 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球PCR技術的市場規模在預測期間內預計以6.3%的年複合成長率發展,從2020年的72億美元,成長到2025年98億美元的規模。

由於感染疾病和遺傳性疾病持續增加,也提高更優秀迅速診斷檢驗的需求。還有投資,基金,津貼等資金也推動R&D的步調。這些要素促進該市場的成長。同時,尤其是dPCR的設備成本高,PCR的技術限制等的課題,預計一定左右抑制市場進一步成長。

本報告提供全球PCR技術的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,法律制度,市場規模的變化、預測,各技術、產品類型、用途、終端用戶、地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 市場課題
    • 趨勢
  • 產業趨勢、COVID-19的影響
  • 法律規章方案
  • 生態系統
  • 波特的五力分析

第6章 市場分析、預測:各技術

  • 傳統PCR
  • 即時PCR
  • 數位PCR
  • 逆轉錄PCR
  • 熱啟動PCR
  • 多工PCR
  • 其他

第7章 市場分析、預測:各產品類型

  • 設備
  • 試劑、消耗品
  • 軟體、服務

第8章 市場分析、預測:各用途

  • 基因表現分析
  • 遺傳的序列測定
  • 基因型鑑定
  • 核酸檢測
  • 核酸合成
  • 標準型有效性確認
  • 診斷
  • 環境
  • 其他

第9章 市場分析、預測:各終端用戶

  • 醫院、診斷中心
  • 醫療保健產業
  • 學術、政府機關
  • 製藥、生物科技企業
  • 應用產業
  • 其他

第10章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第11章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭模式

第12章 企業簡介

  • 主要企業
    • THERMO FISHER SCIENTIFIC, INC.
    • F. HOFFMAN-LA ROCHE LTD.
    • BIO-RAD LABORATORIES, INC.
    • QIAGEN N.V.
    • TAKARA BIO, INC.
    • AGILENT TECHNOLOGIES, INC.
    • BIOMERIEUX S.A.
    • FLUIDIGM CORPORATION
    • DANAHER CORPORATION
    • ABBOTT LABORATORIES
  • 其他企業
    • MERCK KGAA
    • BECTON, DICKINSON AND COMPANY
    • PROMEGA CORPORATION
    • EPPENDORF AG
    • ANALYTIK JENA AG

第13章 附錄

目錄
Product Code: AST 7880

The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 6.3% from 2020 to 2025. The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the PCR technologies market along with the availability of strong financial support in the form of investments, funds, and grants. These factors are driving the growth of PCR technologies market during the forecast period. However, high instrument costs-especially that of dPCR-and the technical limitations of PCR are expected to limit market growth to a certain extent.

"The qPCR segment is expected to account for the largest market share of the global PCR technologies market in 2020."

The qPCR segment is expected to account for the largest share among PCR techniques in 2020. The expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life sciences research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR market.

"Reagents and consumables segment to show the highest growth in the PCR technologies market during the forecast period."

The reagents and consumables segment will show the highest growth in the PCR technologies market during the forecast period. The growth of this segment can be attributed to factors such as the expanding applications of dPCR, the increasing number of dPCR-based analytical procedures among institutional researchers (such as CROs and pharma-biotech companies), and the rising availability of novel dPCR reagents worldwide. Additionally, the expansion of the application base of the dPCR technology in genetic/molecular research, clinical diagnosis, and forensics is expected to result in the commercialization of novel dPCR reagents.

"North America to account for the largest share of the global market in 2020."

North America accounts for the largest share of the PCR technologies market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of PCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand for PCR products in this region

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 48%, Tier 2: 36%, and Tier 3: 16%
  • By Designation: C-level 10%, D-level: 14%, and Others: 76%
  • By Region: North America: 40%, Europe: 32%, APAC: 20%, Latin America: 5%, and the Middle East & Africa: 3%

The major players in the market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), Analytik Jena AG (Germany), Becton Dickinson and Company (US), bioMerieux S.A. (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Fluidigm Corporation (US), Merck KGaA (Germany), Promega Corporation (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (US).

Research Coverage

This report studies the PCR technologies market based on product and services, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the market, and high-growth regions, as well as their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: PCR TECHNOLOGIES MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
    • 2.2.2 USAGE-BASED MARKET ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL PCR TECHNOLOGIES MARKET
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 6 PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 7 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 PCR TECHNOLOGIES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 APAC MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD

4 PREMIUM INSIGHTS

  • 4.1 PCR TECHNOLOGIES MARKET OVERVIEW
    • FIGURE 10 RISING INCIDENCE OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH
  • 4.2 PCR TECHNOLOGIES MARKET SHARE, BY TECHNIQUE, 2020 VS. 2025
    • FIGURE 11 REAL-TIME PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL PCR TECHNOLOGIES MARKETS IN 2020
  • 4.3 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 12 DIAGNOSTIC APPLICATIONS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • 4.4 PCR TECHNOLOGIES MARKET, BY REGION, 2020-2025
    • FIGURE 13 APAC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 14 PCR TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 KEY MARKET DRIVERS
      • 5.2.1.1 Rising incidence of target infectious diseases and genetic disorders
    • FIGURE 15 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2017
    • FIGURE 16 GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES, 2019 VS. 2050 (MILLION)
      • 5.2.1.2 Continuous advancements in PCR technologies
    • FIGURE 17 TRADITIONAL PCR VS. QPCR AND DPCR
      • 5.2.1.3 Increasing investments, funds, and grants
      • 5.2.1.4 Increasing use of biomarker profiling for disease diagnostics
      • 5.2.1.5 Successful completion of the human genome project
    • 5.2.2 KEY MARKET RESTRAINTS
      • 5.2.2.1 High device costs associated with dPCR
      • 5.2.2.2 Technical limitations of qPCR and dPCR
    • 5.2.3 KEY MARKET OPPORTUNITIES
      • 5.2.3.1 Growing market penetration in emerging countries
      • 5.2.3.2 Shift from plant-derived to genome-based drug discovery
    • 5.2.4 KEY MARKET CHALLENGES
      • 5.2.4.1 Adoption and implementation of MIQE guidelines
    • 5.2.5 KEY MARKET TRENDS
      • 5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices
      • 5.2.5.2 Ongoing technological integration with the PCR process
  • 5.3 INDUSTRY TRENDS RELATED TO COVID-19
  • 5.4 GLOBAL REGULATORY SCENARIO
  • 5.5 ECOSYSTEM: PARENT MARKET
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 DEGREE OF COMPETITION
    • 5.6.2 BARGAINING POWER OF SUPPLIERS
    • 5.6.3 BARGAINING POWER OF BUYERS
    • 5.6.4 THREAT OF NEW ENTRANTS
    • 5.6.5 THREAT OF SUBSTITUTES

6 PCR TECHNOLOGIES MARKET, BY TECHNIQUE

  • 6.1 INTRODUCTION
    • TABLE 1 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
  • 6.2 CONVENTIONAL PCR
    • 6.2.1 HIGH ADOPTION OF THIS TECHNIQUE AND ITS DIVERSE APPLICATIONS TO SUSTAIN MARKET GROWTH
    • TABLE 2 CONVENTIONAL PCR MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 3 CONVENTIONAL PCR MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 4 CONVENTIONAL PCR MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 5 CONVENTIONAL PCR MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.3 REAL-TIME PCR
    • 6.3.1 GROWING ADOPTION AMONG RESEARCHERS AND HEALTHCARE PROFESSIONALS TO FUEL MARKET GROWTH
    • TABLE 6 REAL-TIME PCR MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 7 REAL-TIME PCR MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 8 REAL-TIME PCR MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 9 REAL-TIME PCR MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.4 DIGITAL PCR
    • 6.4.1 ONGOING TECHNOLOGICAL DEVELOPMENTS WITH RESPECT TO DIGITAL PCR TO DRIVE MARKET GROWTH
    • TABLE 10 DIGITAL PCR MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 11 DIGITAL PCR MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 12 DIGITAL PCR MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 13 DIGITAL PCR MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.5 REVERSE TRANSCRIPTION PCR
    • 6.5.1 HIGHER SENSITIVITY FOR MRNA DETECTION IS A MAJOR CONTRIBUTING FACTOR TO MARKET GROWTH
    • TABLE 14 REVERSE TRANSCRIPTION PCR MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 15 REVERSE TRANSCRIPTION PCR MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 16 REVERSE TRANSCRIPTION PCR MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 17 REVERSE TRANSCRIPTION PCR MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.6 HOT-START PCR
    • 6.6.1 HASSLE-FREE SETUP OF SAMPLES IS A KEY ADVANTAGE OFFERED BY THIS TECHNIQUE
    • TABLE 18 HOT-START PCR MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 19 HOT-START PCR MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 20 HOT-START PCR MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 21 HOT-START PCR MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.7 MULTIPLEX PCR
    • 6.7.1 COST-EFFECTIVENESS OF THIS TECHNIQUE TO DRIVE MARKET GROWTH
    • TABLE 22 MULTIPLEX PCR MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 23 MULTIPLEX PCR MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 24 MULTIPLEX PCR MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 25 MULTIPLEX PCR MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 6.8 OTHER PCR TECHNIQUES
    • TABLE 26 OTHER PCR TECHNIQUES MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 27 OTHER PCR TECHNIQUES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 28 OTHER PCR TECHNIQUES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 29 OTHER PCR TECHNIQUES MARKET, BY END USER, 2018-2025 (USD MILLION)

7 PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE

  • 7.1 INTRODUCTION
    • TABLE 30 PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
  • 7.2 INSTRUMENTS
    • 7.2.1 INCREASING AVAILABILITY OF INNOVATIVE PCR INSTRUMENTS WILL DRIVE MARKET GROWTH
    • TABLE 31 PCR INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.3 REAGENTS AND CONSUMABLES
    • 7.3.1 INCREASING NUMBER OF ANALYTICAL PROCEDURES AMONG RESEARCHERS TO FUEL MARKET GROWTH
    • TABLE 32 PCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 7.4 SOFTWARE AND SERVICES
    • 7.4.1 AUTOMATION AND DIGITALIZATION OF LABORATORY PROCESSES TO FUEL ADOPTION AMONG END USERS
    • TABLE 33 PCR SOFTWARE AND SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)

8 PCR TECHNOLOGIES MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 34 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.2 GENE EXPRESSION ANALYSIS
    • 8.2.1 GENE EXPRESSION ANALYSIS IS USED IN EPIGENETICS, SIRNA QUANTIFICATION, MRNA ANALYSIS, AND CELL LINE VALIDATION
    • TABLE 35 PCR TECHNOLOGIES MARKET FOR GENE EXPRESSION ANALYSIS, BY REGION, 2018-2025 (USD MILLION)
  • 8.3 GENETIC SEQUENCING
    • 8.3.1 REDUCED COST OF SEQUENCING TO DRIVE MARKET GROWTH
    • TABLE 36 PCR TECHNOLOGIES MARKET FOR GENETIC SEQUENCING, BY REGION, 2018-2025 (USD MILLION)
  • 8.4 GENOTYPING
    • 8.4.1 SNP GENOTYPING CAN ACCELERATE THE ERA OF PERSONALIZED MEDICINE
    • TABLE 37 PCR TECHNOLOGIES MARKET FOR GENOTYPING, BY REGION, 2018-2025 (USD MILLION)
  • 8.5 NUCLEIC ACID DETECTION
    • 8.5.1 PCR TECHNIQUES HAVE WIDE APPLICATIONS IN NUCLEIC ACID DETECTION
    • TABLE 38 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID DETECTION, BY REGION, 2018-2025 (USD MILLION)
  • 8.6 NUCLEIC ACID SYNTHESIS
    • 8.6.1 DNA SYNTHESIS HAS OPENED AVENUES FOR PROGRESS IN BIOLOGY
    • TABLE 39 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID SYNTHESIS, BY REGION, 2018-2025 (USD MILLION)
  • 8.7 STANDARD VALIDATION/VERIFICATION
    • 8.7.1 PCR TECHNIQUES ARE USED FOR REGIONAL/GLOBAL VALIDATION TO FRAME COMMERCIAL/NON-COMMERCIAL GUIDELINES
    • TABLE 40 PCR TECHNOLOGIES MARKET FOR STANDARD VALIDATION/VERIFICATION, BY REGION, 2018-2025 (USD MILLION)
  • 8.8 DIAGNOSTIC APPLICATIONS
    • 8.8.1 DIAGNOSTIC APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
    • TABLE 41 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 8.9 ENVIRONMENTAL APPLICATIONS
    • 8.9.1 PCR IS THE MOST SENSITIVE TECHNIQUE TO DETECT PATHOGENS IN ENVIRONMENTAL SAMPLES
    • TABLE 42 PCR TECHNOLOGIES MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 8.10 OTHER APPLICATIONS
    • TABLE 43 PCR TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)

9 PCR TECHNOLOGIES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 44 PCR TECHNOLOGIES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 9.2 HOSPITALS AND DIAGNOSTIC CENTERS
    • 9.2.1 HIGH PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH
    • TABLE 45 PCR TECHNOLOGIES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2018-2025 (USD MILLION)
  • 9.3 HEALTHCARE INDUSTRY
    • 9.3.1 PCR HAS WIDE APPLICATIONS IN THE HEALTHCARE INDUSTRY
    • TABLE 46 PCR TECHNOLOGIES MARKET FOR HEALTHCARE INDUSTRY, BY REGION, 2018-2025 (USD MILLION)
  • 9.4 ACADEMIA AND GOVERNMENT ORGANIZATIONS
    • 9.4.1 AVAILABILITY OF COST-EFFECTIVE AND INNOVATIVE PCR PRODUCTS TO DRIVE ADOPTION
    • TABLE 47 PCR TECHNOLOGIES MARKET FOR ACADEMIA AND GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)
  • 9.5 PHARMA-BIOTECH COMPANIES
    • 9.5.1 INCREASING R&D INITIATIVES BY PHARMA-BIOTECH COMPANIES TO FUEL THE ADOPTION OF PCR TECHNOLOGIES
    • TABLE 48 PCR TECHNOLOGIES MARKET FOR PHARMA-BIOTECH COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • 9.6 APPLIED INDUSTRIES
    • 9.6.1 INCREASING ENVIRONMENTAL REGULATIONS TO DRIVE THE ADOPTION OF PCR TECHNIQUES
    • TABLE 49 PCR TECHNOLOGIES MARKET FOR APPLIED INDUSTRIES, BY REGION, 2018-2025 (USD MILLION)
  • 9.7 OTHER END USERS
    • TABLE 50 PCR TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)

10 PCR TECHNOLOGIES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 51 PCR TECHNOLOGIES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 18 NORTH AMERICA: PCR TECHNOLOGIES MARKET SNAPSHOT
    • TABLE 52 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 53 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • TABLE 54 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Growing adoption of PCR techniques in research & academia to drive market growth
    • TABLE 56 US: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada
    • TABLE 57 CANADA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 58 EUROPE: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 59 EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • TABLE 60 EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 61 EUROPE: PCR TECHNOLOGIES MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Large-scale outsourcing of clinical diagnostic testing by hospitals to drive market growth
    • TABLE 62 GERMANY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Growing focus on genomics research to support market growth in the UK
    • TABLE 63 UK: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Initiatives for developing genomic medicine to support market growth in France
    • TABLE 64 FRANCE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing R&D investments by pharmaceutical companies to propel market growth
    • TABLE 65 ITALY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing prevalence of chronic and infectious diseases to drive market growth
    • TABLE 66 SPAIN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 67 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 19 ASIA PACIFIC: PCR TECHNOLOGIES MARKET SNAPSHOT
    • TABLE 68 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 71 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan
    • TABLE 72 JAPAN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Healthcare infrastructure modernization to support market growth in China
    • TABLE 73 CHINA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Presence of a large target patient population to support market growth in India
    • TABLE 74 INDIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 High healthcare expenditure in the country to support market growth
    • TABLE 75 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Growing number of private hospitals and independent testing laboratories to drive market growth
    • TABLE 76 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 77 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 78 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 79 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • TABLE 80 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 81 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil is expected to dominate the LATAM market
    • TABLE 82 BRAZIL: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Favorable trade agreements will support imports and improve the accessibility to PCR instruments in Mexico
    • TABLE 83 MEXICO: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 84 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
  • 10.6 MIDDLE EAST AND AFRICA
    • 10.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA
    • TABLE 85 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018-2025 (USD MILLION)
    • TABLE 86 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018-2025 (USD MILLION)
    • TABLE 87 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY END USER, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
    • FIGURE 20 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE PCR TECHNOLOGIES MARKET, 2017-2020
  • 11.2 GLOBAL MARKET SHARE ANALYSIS
    • 11.2.1 GLOBAL PCR TECHNOLOGIES MARKET SHARE ANALYSIS (2019)
    • FIGURE 21 GLOBAL PCR TECHNOLOGIES MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
  • 11.3 COMPETITIVE LEADERSHIP MAPPING
    • 11.3.1 STARS
    • 11.3.2 EMERGING LEADERS
    • 11.3.3 PERVASIVE
    • 11.3.4 PARTICIPANTS
    • FIGURE 22 PCR TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
    • FIGURE 23 PCR TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
  • 11.4 COMPETITIVE SCENARIO
    • TABLE 88 PCR TECHNOLOGIES MARKET: PRODUCT LAUNCHES AND APPROVALS, 2017-2020
    • TABLE 89 PCR TECHNOLOGIES MARKET: EXPANSIONS, 2017-2020
    • TABLE 90 PCR TECHNOLOGIES MARKET: ACQUISITIONS, 2017-2020

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
  • (Business Overview, Products & services offered, Recent Developments, SWOT Analysis, MnM View)**
    • 12.1.1 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 91 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 24 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019)
    • TABLE 92 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS & SERVICES OFFERED
    • 12.1.2 F. HOFFMAN-LA ROCHE LTD.
    • TABLE 93 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 25 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
    • TABLE 94 EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD)
    • TABLE 95 ROCHE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED
    • 12.1.3 BIO-RAD LABORATORIES, INC.
    • TABLE 96 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 26 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019)
    • TABLE 97 BIO-RAD LABORATORIES, INC.: PRODUCTS AND SERVICES OFFERED
    • 12.1.4 QIAGEN N.V.
    • TABLE 98 QIAGEN N.V.: BUSINESS OVERVIEW
    • FIGURE 27 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
    • TABLE 99 QIAGEN N.V.: PRODUCTS OFFERED
    • 12.1.5 TAKARA BIO, INC.
    • TABLE 100 TAKARA BIO, INC.: BUSINESS OVERVIEW
    • FIGURE 28 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019)
    • TABLE 101 EXCHANGE RATES (UTILIZED FOR CONVERSION OF JPY TO USD)
    • TABLE 102 TAKARA BIO, INC.: PRODUCTS OFFERED
    • 12.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 103 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 29 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019)
    • TABLE 104 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
    • 12.1.7 BIOMERIEUX S.A.
    • TABLE 105 BIOMERIEUX S.A.: BUSINESS OVERVIEW
    • FIGURE 30 BIOMERIEUX S.A.: COMPANY SNAPSHOT (2019)
    • TABLE 106 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)
    • TABLE 107 BIOMERIEUX: PRODUCTS OFFERED
    • 12.1.8 FLUIDIGM CORPORATION
    • TABLE 108 FLUIDIGM CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019)
    • TABLE 109 FLUIDIGM CORPORATION: PRODUCTS OFFERED
    • 12.1.9 DANAHER CORPORATION
    • TABLE 110 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
    • TABLE 111 DANAHER CORPORATION: PRODUCTS OFFERED
    • 12.1.10 ABBOTT LABORATORIES
    • TABLE 112 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
    • TABLE 113 ABBOTT LABORATORIES: PRODUCTS OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 MERCK KGAA
    • TABLE 114 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019)
    • TABLE 115 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)
    • TABLE 116 MERCK KGAA: PRODUCTS & SERVICES OFFERED
    • 12.2.2 BECTON, DICKINSON AND COMPANY
    • TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
    • TABLE 118 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
    • 12.2.3 PROMEGA CORPORATION
    • TABLE 119 PROMEGA CORPORATION: BUSINESS OVERVIEW
    • TABLE 120 PROMEGA CORPORATION: PRODUCTS OFFERED
    • 12.2.4 EPPENDORF AG
    • TABLE 121 EPPENDORF AG: BUSINESS OVERVIEW
    • FIGURE 36 EPPENDORF AG: COMPANY SNAPSHOT (2019)
    • TABLE 122 EXCHANGE RATES (UTILIZED FOR THE CONVERSION OF EUR TO USD)
    • TABLE 123 EPPENDORF AG: PRODUCTS OFFERED
    • 12.2.5 ANALYTIK JENA AG (A WHOLLY OWNED SUBSIDIARY OF ENDRESS+HAUSER AG)
    • TABLE 124 ENDRESS+HAUSER: BUSINESS OVERVIEW
    • FIGURE 37 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2019)
    • TABLE 125 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)
    • TABLE 126 ANALYTIK JENA AG: PRODUCTS OFFERED
  • *Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS